• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Raised Guidance Will Impact Concentra Group Holdings Parent Stock (CON)

    Simply Wall St·11/14/2026 18:21:00
    Listen to the news
    • Concentra Group Holdings Parent reported third quarter 2026 sales of US$622.12 million and net income of US$65.89 million. The company also reported higher nine month figures and declared a cash dividend of US$0.0625 per share for December payment.
    • The business paired these results with raised full year 2026 revenue and profit guidance and announced a new US$250 million share repurchase authorization in addition to completed buybacks, indicating active capital deployment alongside its occupational health growth strategy.
    • We will now look at how Concentra Group Holdings Parent's raised full year guidance could reshape the existing investment narrative around the stock.

    Compare Concentra Group Holdings Parent's latest guidance and buyback plans against other potential opportunities by scanning our hand picked 20 high quality undiscovered gems with strong fundamentals and room to prove themselves.

    Concentra Group Holdings Parent Investment Narrative Recap

    For an investor to stay with Concentra Group Holdings Parent, the core belief is that occupational health demand and the company’s scaled clinic and telemed network can sustain steady earnings, even if visit growth is modest. The analyst consensus Narrative on Simply Wall St already flags that growth expectations are not high. The raised 2026 guidance reinforces that, in the near term, execution on this existing path remains the key driver.

    The flip side is still operational leverage and cost control. Higher G&A, acquisition integration and elevated debt were key risks before this quarter. The updated outlook softens some earnings concerns in the short run but does not remove the longer term risks around leverage, margin pressure and slower industry volume growth.

    The most relevant announcement for this story is the higher full year 2026 guidance, with Concentra Group Holdings Parent now expecting revenue of US$2.36b to US$2.38b and net income attributable to the company of US$216m to US$220m. That range matters because it frames what management thinks is achievable after nine months of actuals.

    For investors, that guidance ties directly into the main catalyst and the main risk. Delivery against those numbers would support the current earnings trajectory that analysts are building into their models, while any shortfall would put more focus on the firm’s leverage and the need to keep integrating acquisitions cleanly. The new US$250m buyback then sits on top of that execution test, since it uses balance sheet capacity that could otherwise be used to reduce debt more quickly.

    What The Long Range Assumptions Mean For Concentra Group Holdings Parent

    Analysts are effectively asking investors to think of Concentra Group Holdings Parent as a slow and steady compounder. The current forecast assumes revenue growth of 5.8% per year over the next three years, with profit margins rising from 9.1% today to 9.8% by 2029 as integration work and clinic scale feed through. That is a measured path rather than a high growth story, and it aligns with the occupational health backdrop that management has been describing on recent calls.

    Earnings expectations line up with that theme. Consensus projects net income of US$269.6 million in 2029, compared with US$211.8 million today. That is an increase of roughly US$57.8 million over the period, which implies analysts see room for incremental margin lift on top of the mid single digit revenue trajectory. For anyone tracking guidance, it is also consistent with the higher full year 2026 outlook that management has just provided, since the 2029 number effectively extends that earnings profile a few more years along the same track.

    Valuation assumptions in the report are equally restrained. To get to the current analyst price targets, the stock would need to trade on a P/E of 24.7x in 2029, down from 25.2x today and slightly below the cited US healthcare sector multiple of 24.9x. In other words, the case here is not multiple expansion. It is gradual earnings growth, mild margin improvement and a modest reduction in the share count as analysts model a 1.29% annual decline in outstanding shares over the next three years through buybacks.

    Concentra Group Holdings Parent's narrative projects US$2.8b revenue and US$269.6 million earnings by 2029. This requires 5.8% yearly revenue growth and an earnings increase of about US$57.8 million from current earnings of US$211.8 million.

    Uncover why Concentra Group Holdings Parent's fair value indicates a 4% potential upside to its current price that could narrow quickly.

    NYSE:CON 1-Year Stock Price Chart
    NYSE:CON 1-Year Stock Price Chart

    Exploring Other Perspectives

    One alternate view on Concentra Group Holdings Parent focuses on whether recent workers' comp visit strength can last. The most cautious analysts were modeling about US$2.7b in 2029 revenue and US$261.5 million in earnings before this quarter, and they see that momentum fading. You can treat this quarter's raised guidance as a live test of that more pessimistic storyline.

    Explore 2 other Concentra Group Holdings Parent fair value estimates, including one that suggests as much as 6% downside from the current price.

    Reach Your Own Conclusion

    Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

    Looking For More Investment Ideas Beyond Concentra Group Holdings Parent?

    If the Concentra Group Holdings Parent story has sharpened your thinking but you want a broader watchlist, use the Simply Wall St Screener to scan for other companies that match your preferences on quality, valuation and risk.

    • For investors who want income without ignoring quality, review a curated set of resilient payers through the 6 dividend fortresses that may align with your yield and stability goals.
    • If capital preservation and steadier profiles matter most to you, narrow your universe to a 31 resilient stocks with low risk scores that filters for businesses with more resilient characteristics.
    • When you want to focus on balance sheet strength and fundamental resilience, start with a list of solid balance sheet and fundamentals (24 results) to see which companies clear your quality bar before you go deeper on valuation.